CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 65 filers reported holding CUE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $51,377 | -32.4% | 14,076 | -58.7% | 0.00% | – |
Q3 2022 | $76,000 | -76.7% | 34,102 | -73.9% | 0.00% | -100.0% |
Q2 2022 | $326,000 | -62.2% | 130,854 | -26.0% | 0.00% | -66.7% |
Q1 2022 | $863,000 | +36.8% | 176,756 | +217.1% | 0.00% | +200.0% |
Q4 2021 | $631,000 | -58.1% | 55,750 | -46.1% | 0.00% | -66.7% |
Q3 2021 | $1,507,000 | -35.6% | 103,430 | -48.5% | 0.00% | -40.0% |
Q2 2021 | $2,340,000 | -40.8% | 200,868 | -38.0% | 0.01% | -50.0% |
Q1 2021 | $3,952,000 | -2.8% | 323,958 | -0.3% | 0.01% | -16.7% |
Q4 2020 | $4,066,000 | -9.9% | 325,000 | +8.4% | 0.01% | -25.0% |
Q3 2020 | $4,512,000 | -21.1% | 299,817 | +28.4% | 0.02% | -42.9% |
Q2 2020 | $5,722,000 | – | 233,451 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |